BenzylideneCamphorSulfonicAcid/4-[(4,7,7-Trimethyl-3-oxobicyclo[2.2.1]hept-2-ylidene)methyl]benzenesulfonicacid 56039-58-8
|
亞芐基樟腦磺酸
|
56039-58-8
|
PuberulicAcid
|
軟毛青霉酸
|
99-23-0
|
Artemether Impurity/(2S,3R,6RS)-2-(3-Oxobutyl)-3-methyl-6-[(R)-2-propanal]cyclohexanone
|
蒿甲醚雜質(zhì)
|
1093625-96-7
|
Adapalene EP Impurity B
|
阿達(dá)帕林EP雜質(zhì)B
|
1346599-76-5
|
Methyl 4,6-dibromonicotinate
|
4,6-二溴煙酸甲酯
|
1364663-27-3
|
Beclomethasone Dipropionate EP Impurity L
|
二丙酸倍氯米松EP雜質(zhì)L
|
114371-33-4
|
Methyl2-acetoxy-5-acetylbenzoate 61414-18-4
|
2-乙酰氧基-5-乙酰基苯甲酸甲酯
|
61414-18-4
|
2-Acetyl Azacitidine
|
阿扎胞苷雜質(zhì)
|
1174733-90-4
|
LevofloxacinEPImpurityGHCl
|
左氧氟沙星相關(guān)物質(zhì)E
|
1346603-62-0
|
Denitronitazoxanide
|
硝唑尼特雜質(zhì)
|
402848-76-4
|
BenzydamineEPImpurityBHCl
|
1-Propanamine, 3-[[1,5-bis(phenylmethyl)-1H-indazol-3-yl]oxy]-N,N-dimethyl-, hydrochloride (1:1)
|
2196183-71-6
|
OndansetronEPImpurityB
|
昂丹司瓊EP雜質(zhì)B
|
1076198-52-1
|
Fudosteine Sulfoxide
|
福多司坦砜亞砜雜質(zhì)
|
209665-22-5
|
Ibrutinib Impurity/(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)
|
1642630-12-3
|
GemfibrozilEPImpurityD
|
吉非貝齊EP雜質(zhì)D
|
1798429-95-4
|
Baricitinib Impurity
|
1627504-41-9
|
1627504-41-9
|
(2R,3R,4R,5S)-2,3,4,5,6-pentahydroxyhexyl4-hydroxybenzoate 334948-52-6
|
(2R,3R,4R,5S)-2,3,4,5,6-五羥基己基4-羥基苯甲酸酯
|
334948-52-6
|
Cyclophosphamide USP RC C
|
磷酸二氫氨基丙酯
|
1071-28-9
|
Baricitinib Impurity
|
巴瑞克替尼雜質(zhì)04
|
2497340-56-2
|
N-NitrosoVonoprazan
|
沃諾拉贊雜質(zhì)171
|
2932441-73-9
|
PhloroglucinolImpurity2
|
三甲基間苯三酚雜質(zhì)
|
96259-88-0
|
(6S)-5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one7,7-dioxide
|
多佐胺雜質(zhì)
|
148719-91-9
|
2-Methyl-4-penten-1-ol 5673-98-3
|
|
5673-98-3
|
Lamotrigine EP Impurity G
|
拉莫三嗪EP雜質(zhì)G
|
38943-76-9
|
Axitinib Sulfoxide
|
阿昔替尼雜質(zhì)
|
1347304-18-0
|
(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)ethan-1-one
|
依魯替尼雜質(zhì)31
|
1288338-95-3
|
6-Chloro-5-methyl-pyridine-2-carbaldehyde
|
|
223633-48-5
|
3,3'-((2-(12-(benzyloxy)-12-oxododecanamido)-2-((2-carboxyethoxy)methyl)propane-1,3-diyl)bis(oxy))dipropionic acid
|
3,3'-((2-(12-(芐氧基)-12-氧代十二烷酰胺基)-2-((2-羧乙氧基)甲基)丙烷-1,3-二基)雙(氧基))二丙酸
|
2241043-42-3
|
1,2,4-Trimethoxy-5-(2,4,5-trimethoxyphenyl)benzene
|
間苯三酚雜質(zhì)D
|
1702-67-6
|
CyclophosphamideMonochloroImpurity
|
環(huán)磷酰胺相關(guān)化合物B
|
158401-52-6
|
Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-acetylpyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate
|
達(dá)卡他韋雜質(zhì)
|
2226541-13-3
|
Anastrozole Impurity
|
阿那曲唑雜質(zhì)
|
1186102-55-5
|
Benserazide Trihydroxybenzylhydrazine Impurity
|
三羥芐肼
|
3614-72-0
|
1,1-diprop-2-enoxybutane
|
米洛巴林中間體
|
35020-94-1
|
SodiumPicosulfateEPImpurityA
|
匹可硫酸鈉EP雜質(zhì)A
|
51264-33-6
|
5-BROMO-2-(2-METHYL-2H-TETRAZOL-5-YL)-PYRIDINE
|
2-甲基-5-(5-溴吡啶-2-基)四氮唑
|
380380-64-3
|
Adapalene EP Impurity C
|
阿達(dá)帕林EP雜質(zhì)C
|
43109-77-9
|
CetirizineEPImpurityEDiHCl
|
西替利嗪雜質(zhì)E
|
83881-56-5
|
TicagrelorImpurity29
|
替格瑞洛雜質(zhì)
|
1823431-32-8
|
Scopolamine EP Impurity B
|
東莨菪堿 EP 雜質(zhì) B
|
535-26-2
|
1’-HydroxyBilastine
|
比拉斯汀雜質(zhì)5
|
1638785-23-5
|
rac-Mirabegron
|
米拉貝隆雜質(zhì)
|
1330277-46-7
|
NitazoxanideImpurity3
|
硝唑尼特雜質(zhì)3
|
952686-58-7
|
IsothipendylImpurity1HCl
|
異噻吩基雜質(zhì)1 HCl
|
132962-42-6
|
Fluconazole EPImpurity C
|
氟康唑EP雜質(zhì)C
|
514222-44-7
|
2-[3,5-Bis(trifluoromethyl)phenyl]propanoicacid 289686-73-3
|
2-[3,5-Bis(trifluoromethyl)phenyl]propanoic Acid
|
289686-73-3
|
Baricitinib Acetic Acid Impurity
|
巴瑞替尼雜質(zhì) 17
|
2271228-52-3
|
2-(1-cyclohexenyl)ethylamine
|
環(huán)己烯乙胺
|
3399-73-3
|
1,3-Dibromo-5-(tert-butyl)-2-nitrobenzene
|
1,3-二溴-5-(叔丁基)-2-硝基苯
|
2828612-34-4
|
Remifentanil EP Impurity A HCl
|
瑞芬太尼EP雜質(zhì)A鹽酸鹽
|
61085-87-8
|
Amlodipine EP Impurity H
|
氨氯地平雜質(zhì)H
|
318465-73-5
|
LoxoprofenRing-openingImpurity
|
洛索洛芬開環(huán)雜質(zhì)
|
1091621-61-2
|
Rosuvastatin EP Impurity G Sodium Salt
|
瑞舒伐他汀EP雜質(zhì)G鈉鹽
|
1242184-42-4
|
Desmethyl Etoricoxib
|
依托考昔去甲基雜質(zhì)
|
202409-31-2
|
(R)-N-Desacryloyl N-3-Propionyl Ibrutinib
|
(R)-1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-chloropropan-1-one
|
1288338-96-4
|
SuvorexantRegioisomer(5R)
|
Suvorexant Impurity 2
|
1276666-19-3
|
1-(4-Methanesulfinylphenyl)ethan-1-one
|
1-(4-甲亞磺?;交?乙-1-酮
|
32361-73-2
|
N-Fmoc-3R-hydroxypyrrolidine-5S-methanol
|
(2S,4R)-(9H-fluoren-9-yl)methyl 4-hydroxy-2-(hydroxymethyl)pyrrolidine-1-carboxylate
|
163671-09-8
|
LovastatinEPImpurityB75225-50-2
|
洛伐他汀鈉
|
75225-50-2
|
Dodecanedioic acid, mono(phenylmethyl) ester
|
十二烷二酸單芐酯
|
88353-04-2
|
FurosemideEPImpurityC
|
呋塞米EP雜質(zhì)C
|
3086-91-7
|
Imatinib EP Impurity D Chloride
|
伊馬替尼EP雜質(zhì)D
|
1821122-73-9
|
Baricitinib Impurity
|
巴瑞替尼雜質(zhì)9
|
1187594-34-8
|
Azacitidine USP RC C
|
阿扎胞苷雜質(zhì)
|
2508-80-7
|
Cyclosporin L
|
環(huán)孢菌素L
|
108027-39-0
|
Riociguat
|
利奧西呱
|
625115-55-1
|
NaratriptanN-oxide
|
納拉曲坦N氧化物
|
1159977-52-2
|
NebivololDidesfluoro129101-33-3
|
二脫氟奈必洛爾
|
129101-33-3
|
LevothyroxineAcetamideImpurity
|
左甲狀腺素乙酰胺雜質(zhì)
|
176258-88-1
|
MacitentanImpurity9/2-[[5-(4-Bromophenyl)-6-[[(propylamino)sulfonyl]amino]-4-pyrimidinyl]oxy]-aceticacid 1433875-14-9
|
ACT 373898
|
1433875-14-9
|
Baricitinib Acetamide Impurity
|
巴瑞克替尼雜質(zhì)01
|
2271228-51-2
|
NA
|
甲基潑尼松龍乙丁酸酯
|
86413-29-8
|
CarbamazepineEPImpurityA
|
卡馬西平EP雜質(zhì)A
|
3564-73-6
|
LidocaineEPImpurityKHCl
|
利多卡因EP雜質(zhì)K鹽酸鹽
|
50295-20-0
|
5-(4-Bromophenyl)-6-hydroxypyrimidin-4(1H)-one
|
5-(4-溴苯基)-6-羥基嘧啶-4(1H)-酮
|
706811-25-8
|
CyclophosphamideImpurityB
|
環(huán)磷酰胺雜質(zhì)B
|
22089-17-4
|
6-Bromo-4-chloronicotinic acid
|
4-氯-6-溴煙酸
|
1060808-92-5
|
TicagrelorImpurity46
|
替格瑞洛雜質(zhì)
|
1482484-62-7
|
Ruxolitinib Diamine
|
魯索利尼雜質(zhì)G
|
952518-97-7
|
Penilloaldehyde
|
Benzeneacetamide, N-(2-oxoethyl)-
|
5663-61-6
|
PantoprazoleMagnesiumDihydrate
|
|
259669-63-1
|
Dutasteride EP Impurity E
|
度他雄胺EP雜質(zhì)E
|
2102935-76-0
|
Methyl 4-(2-methoxyphenyl)-2,4-dioxobutanoate
|
4-(2-甲氧基苯基)-2,4-二氧代丁酸甲酯
|
848052-89-1
|
IsotretinoinEPImpurityH
|
4-酮13-順式維甲酸
|
71748-58-8
|
2,2,8,8-Tetramethylnonanedioic acid
|
2,2,8,8-四甲基壬二酸
|
30313-67-8
|
Ruxolitinib Hydroxy Impurity
|
巴里替尼雜質(zhì)5
|
1187595-89-6
|
2-Methyl-1-phenylbutane-1,3-dione
|
2-甲基-1-苯基-1,3-丁二酮
|
6668-24-2
|
2,4,6,3',5'-pentamethoxybiphenyl 84212-55-5
|
2,4,6,3',5'-PENTAMETHOXYBIPHENYL
|
84212-55-5
|
2-Methylpentane-1,5-diol 42856-62-2
|
2-甲基-1,5-戊二醇
|
42856-62-2
|
SertralineEPImpurityDHCl
|
舍曲林EP雜質(zhì)D鹽酸鹽
|
2378750-29-7
|
Octadecanedioic acid mono-tert‐butyl ester
|
十八烷二酸單叔丁酯
|
843666-40-0
|
2,6-Diazaspiro[3.3]heptane-2-carboxylic acid tert-butyl ester hemioxylate
|
2-boc-2,6二氮雜螺[3.3]庚烷草酸鹽
|
1041026-71-4
|
SodiumPicosulfateEPImpurityASodiumSalt
|
匹可硫酸鈉EP雜質(zhì)A鈉鹽
|
32500-19-9
|
Beclomethasone Dipropionate EP Impurity N
|
二丙酸倍氯米松EP雜質(zhì)N
|
1204582-47-7
|
Beclomethasone Dipropionate EP Impurity F
|
二丙酸倍氯米松EP雜質(zhì)F
|
887130-69-0
|
Ethyl 5-amino-1-(2-fluorobenzyl)-1H-pyrazole-3-carboxylate
|
5-氨5-氨基-1-(2-氟芐基)-1H-吡唑-3-羧酸乙酯基-1-(2-氟芐基)-1H-吡唑-3-羧酸乙酯
|
256504-39-9
|
AmbroxolMonobromineImpurity
|
氨溴索雜質(zhì)
|
101900-43-0
|
3-Amino-5-methoxyphenol
|
3-amino-5-methoxyphenol
|
162155-27-3
|
4,5-Dichloro-3,6-dihydroxyphthalonitrile 4640-41-9
|
DDQ副產(chǎn)物
|
4640-41-9
|
4,5-Dimethyl-3-phenyl-1H-pyrazole
|
|
13618-35-4
|
5-Bromo-1-methyl-1H-pyrrole-3-carboxylic acid
|
5-溴-1-甲基-1H-吡咯-3-甲酸
|
1515982-14-5
|
Cetirizine EP Impurity C DiHCl Salt
|
鹽酸西替利嗪EP雜質(zhì)C二鹽酸鹽
|
2702511-37-1
|
Hydrochlorothiazide5-ChloroImpurity
|
氫氯噻嗪雜質(zhì)
|
856302-12-0
|
TriamtereneEPImpurityC 19152-93-3
|
氨苯蝶啶雜質(zhì)C
|
19152-93-3
|
2-Propenylpropylpropanedioic Acid Diethyl Ester
|
2-Propenylpropylpropanedioic Acid Diethyl Ester
|
59726-38-4
|
Amoxicillin EP Impurity G
|
阿莫西林EP雜質(zhì)G
|
188112-75-6
|
(R)-Medetomidine HCl
|
鹽酸左美托嘧啶
|
190000-46-5
|
FormoterolEPImpurityA(MixtureofDiastereomers)
|
福莫特羅雜質(zhì)13
|
150513-24-9
|
Norethynodrel
|
異炔諾酮
|
68-23-5
|
4-Methoxybenzyl hydrazinecarboxylate
|
4-甲氧基苯基碳酸酯
|
18912-37-3
|
Octadecanedioic Acid
|
十八烷二酸
|
871-70-5
|
Beclomethasone Dipropionate EP Impurity A
|
二丙酸倍氯米松EP雜質(zhì)A
|
69224-79-9
|